Company has informed the exchange about certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2025
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience has submitted a certificate to NSE as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025. This certificate is typically issued by the company's Registrar and Share Transfer Agent (RTA) to confirm that share certificates received for dematerialisation during the quarter have been duly processed. This is a routine, mandatory quarterly compliance filing with no material business or financial impact.
No impact on shareholders or stock price. This is a standard procedural filing confirming compliance with SEBI's dematerialisation rules and does not signal any change in business performance or strategy.